MetaADEDB 2.0 @ LMMD
Clopenthixol
(WFPIAZLQTJBIFN-DVZOWYKESA-N)
Structure
SMILES
OCCN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(Cl)cc2
Molecular Formula:
C22H25ClN2OS
Molecular Weight:
400.965
Log P:
4.1121
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
1
TPSA:
52.01
CAS Number(s):
53772-83-1
Synonym(s)
1.
Clopenthixol
2.
Cisordinol
3.
Zuclopenthixol
4.
alpha-Clopenthixol
5.
alpha Clopenthixol
External Link(s)
MeSHD003006
PubChem Compound5311507
BindingDB79209
81482
ChEBI51364
59115
CHEMBLCHEMBL53904
DrugBankDB13841
DB01624
DrugCentral2877
IUPHAR/BPS Guide to PHARMACOLOGY7559
KEGGdr:D02613
dr:D03556
ZINC601293
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Abdominal PainSIDER
2Abdominal rigidityOFFSIDES
3Abnormal visionSIDER
4Accidental exposureOFFSIDES
5Acute psychosisCanada Vigilance: 1Canada Vigilance
6AgitationSIDER
7AgoraphobiaOFFSIDES
8AgranulocytosisSIDER
9AkathisiaSIDER
10Alanine Aminotransferase IncreasedSIDER
11Alcohol consumptionOFFSIDES
12Altered state of consciousnessOFFSIDES
13AmenorrheaOFFSIDES
14AmnesiaSIDER
15Anaphylactic shockSIDER
16AngerCanada Vigilance: 1Canada Vigilance
17AnorexiaOFFSIDES
SIDER
18Anticonvulsant drug level increasedOFFSIDES
19Antipsychotic drug level below therapeuticOFFSIDES
20AnuriaOFFSIDES
21AnxietyOFFSIDES
SIDER
22ApathyOFFSIDES
SIDER
23AstheniaOFFSIDES
SIDER
24AtaxiaSIDER
25AuraOFFSIDES
26Benign ethnic neutropeniaCanada Vigilance: 1Canada Vigilance
27Blood and lymphatic system disordersSIDER
28Blood chloride decreasedOFFSIDES
29Blood potassium decreasedOFFSIDES
30Blood sodiumOFFSIDES
31Blood thyroid stimulating hormone increasedOFFSIDES
32Body TemperatureOFFSIDES
33Bone marrow toxicityOFFSIDES
34BronchitisOFFSIDES
35BronchopneumoniaOFFSIDES
36BruxismOFFSIDES
37Cardiac HypertrophyOFFSIDES
38CatatoniaOFFSIDES
39Cerebral atrophyOFFSIDES
40Chemotherapeutic drug level increasedOFFSIDES
41Chest PainOFFSIDES
42ConfabulationOFFSIDES
43Congenital diaphragmatic herniaOFFSIDES
44Congenital heart diseaseOFFSIDES
45ConstipationSIDER
46Cytolytic hepatitisOFFSIDES
47Delusional disorder, persecutory typeOFFSIDES
48DemyelinationOFFSIDES
49Depressed moodOFFSIDES
50DermatitisSIDER
51DiscomfortSIDER
52Disturbance in sexual arousalSIDER
53DizzinessSIDER
54DrowsinessOFFSIDES
SIDER
55Drug addictOFFSIDES
56Drug exposure during pregnancyOFFSIDES
57Drug withdrawal syndromeSIDER
58DysarthriaCanada Vigilance: 1Canada Vigilance
59DyspepsiaSIDER
60Dysthymic DisorderOFFSIDES
61DystoniaOFFSIDES
62DysuriaSIDER
63Ear and labyrinth disordersSIDER
64EcholaliaOFFSIDES
65EczemaOFFSIDES
66Electrocardiogram ST-T changeOFFSIDES
67EosinophiliaSIDER
68Eosinophilic myocarditisOFFSIDES
69Erectile dysfunctionSIDER
70ErythemaSIDER
71Euphoric moodOFFSIDES
72Excessive eye blinkingCanada Vigilance: 1Canada Vigilance
73Fanconi SyndromeOFFSIDES
74FatigueOFFSIDES
SIDER
75Feeling ColdSIDER
76Feeling abnormalSIDER
77Female Orgasmic DisorderSIDER
78Flat affectSIDER
79FlatulenceSIDER
80Flight of ideasOFFSIDES
81GalactorrheaOFFSIDES
82Gastrointestinal PainSIDER
83Gastrointestinal obstructionOFFSIDES
84General physical health deteriorationOFFSIDES
85GlaucomaSIDER
86GlycosuriaSIDER
87Granulocytes abnormalOFFSIDES
88Hallucinations, mixedOFFSIDES
89Head titubationOFFSIDES
90HeadacheSIDER
91Heart sounds abnormalOFFSIDES
92Heat StrokeOFFSIDES
93Hygroma colliOFFSIDES
94HyperacusisSIDER
95HyperkinesiaSIDER
96HyperreflexiaOFFSIDES
SIDER
97HypersensitivitySIDER
98HyperventilationOFFSIDES
99HypokinesiaOFFSIDES
SIDER
100HypomaniaOFFSIDES
101HypotensionSIDER
102Impaired self-careOFFSIDES
103IncontinenceOFFSIDES
104Injection Site ReactionSIDER
105Intestinal ObstructionOFFSIDES
106Intestinal congestionOFFSIDES
107Joint stiffnessCanada Vigilance: 1Canada Vigilance
108LacerationOFFSIDES
109LethargyOFFSIDES
110Leukopenia neonatalOFFSIDES
111LeukopeniaSIDER
112Lip exfoliationOFFSIDES
113Lupus-like syndromeOFFSIDES
114MalaiseSIDER
115MalnutritionSIDER
116Mental impairmentOFFSIDES
117Multiple drug overdoseOFFSIDES
118MumpsOFFSIDES
119Muscle RigiditySIDER
120Muscle relaxant therapySIDER
121Musculoskeletal discomfortSIDER
122MyalgiaSIDER
123MydriasisSIDER
124NasopharyngitisSIDER
125NauseaSIDER
126Nephrogenic Diabetes InsipidusOFFSIDES
127NervousnessSIDER
128Neuroleptic Malignant SyndromeOFFSIDES
SIDER
129NeutropeniaSIDER
130Neutrophil count decreasedCanada Vigilance: 1Canada Vigilance
OFFSIDES
131OculogyrationSIDER
132Oculogyric crisisSIDER
133OpisthotonusSIDER
134Oropharyngeal painOFFSIDES
135OsteolysisOFFSIDES
136OverdoseOFFSIDES
137OverweightOFFSIDES
138PainSIDER
139PalpitationsSIDER
140PancytopeniaSIDER
141PericarditisOFFSIDES
142Personality ChangeOFFSIDES
143Pharyngolaryngeal PainOFFSIDES
144PolyuriaSIDER
145Poor quality sleepOFFSIDES
146Post-Traumatic Stress DisorderCanada Vigilance: 1Canada Vigilance
147Pregnancy test false positiveSIDER
148PregnancySIDER
149PriapismSIDER
150Product prescribing errorCanada Vigilance: 1Canada Vigilance
151Product use in unapproved indicationCanada Vigilance: 1Canada Vigilance
152PruritusSIDER
153PseudoparkinsonismSIDER
154PurpuraSIDER
155QRS axis abnormalOFFSIDES
156Quality of life decreasedOFFSIDES
157RegurgitationOFFSIDES
158Renal cystOFFSIDES
159Renal tubular disorderOFFSIDES
160Schizoaffective DisorderOFFSIDES
161SchizophreniaOFFSIDES
162ShockSIDER
163Shoulder PainOFFSIDES
164Sinus bradycardiaOFFSIDES
165SomnolenceCanada Vigilance: 1Canada Vigilance
SIDER
166Stevens-Johnson SyndromeOFFSIDES
167StressOFFSIDES
168Sudden deathOFFSIDES
SIDER
169SweatingSIDER
170SyncopeSIDER
171TachycardiaCanada Vigilance: 1Canada Vigilance
SIDER
172TachyphreniaOFFSIDES
173Tardive DyskinesiaCanada Vigilance: 1Canada Vigilance
SIDER
174TensionSIDER
175TheftOFFSIDES
176ThirstSIDER
177ThrombocytopeniaSIDER
178TinnitusSIDER
179Tongue spasmOFFSIDES
180TonsillitisOFFSIDES
181TorticollisSIDER
182TremorCanada Vigilance: 1Canada Vigilance
SIDER
183TrismusSIDER
184Troponin I increasedOFFSIDES
185Troponin increasedOFFSIDES
186Urinary RetentionSIDER
187Urine output increasedSIDER
188Vascular purpuraSIDER
189Venous ThromboembolismSIDER
190Ventricular FibrillationSIDER
191Ventricular arrhythmiaSIDER
192VertigoSIDER
193Visual ImpairmentSIDER
194VomitingSIDER
195Vulvovaginal drynessSIDER
196Walking aid userOFFSIDES
197Waxy flexibilityOFFSIDES
198Weight decrease neonatalOFFSIDES
199Weight decreasedSIDER
200White blood cell count decreasedCanada Vigilance: 1Canada Vigilance
201jaundiceSIDER
202nervous system disorderSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.